Cormark Issues Pessimistic Outlook for STERIS’ Earnings

Posted by on Nov 19th, 2024

STERIS’ (TSE:STE – Free Report) – Equities research analysts at Cormark lowered their FY2025 earnings per share estimates for STERIS’ in a research note issued to investors on Monday, November 18th. Cormark analyst B. Watson now anticipates that the company will earn $0.86 per share for the year, down from their prior forecast of $0.94.

STERIS’ Stock Performance

About STERIS’

(Get Free Report)

STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.

Featured Articles

Earnings History and Estimates for STERIS’ (TSE:STE)

Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.